A number of studies reported that CD4+Foxp3+ regulatory T cell frequency was significantly higher in peripheral blood and tumor tissues of patients with HNSCC than in healthy controls and it was correlated with progression of HNSCC [64–67]. This evidence concerns the gene FOXP3 and neoplasm.